Division of Pancreatic Surgery, IRCCS, Azienda Ospedaliero Universitaria di Bologna, S.Orsola-Malpighi Hospital, Via Massarenti n.9, 40138, Bologna, Italy.
Department of Internal Medicine and Surgery (DIMEC), Alma Mater Studiorum, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy.
Updates Surg. 2022 Oct;74(5):1533-1542. doi: 10.1007/s13304-022-01346-x. Epub 2022 Aug 25.
Pancreatic ductal adenocarcinoma (PDAC) is an increasing disease having a poor prognosis. The aim of the present study was to evaluate the effect of different models of care for pancreatic cancer in a tertiary referral centre in the period 2006-2020. Retrospective study of patients with PDAC observed from January 2006 to December 2020. The demographic and clinical data, and data regarding the imaging techniques used, preoperative staging, management, survival and multidisciplinary tumour board (MDTB) evaluation were collected and compared in three different periods characterised by different organisation of pancreatic cancer services: period A (2006-2010); period B (2011-2015) and period C (2016-2020). One thousand four hundred seven patients were analysed: 441(31.3%) in period A; 413 (29.4%) in B and 553 (39.3%) in C. The proportion of patients increased significantly, from 31.3% to 39.3% (P = 0.032). Body mass index (P = 0.033), comorbidity rate (P = 0.002) and Karnofsky performance status (P < 0.001) showed significant differences. Computed tomography scans (P < 0.001), endoscopic ultrasound (P < 0.001), fine needle aspiration, fine needle biopsy (P < 0.001), and fluorodeoxyglucose-positron emission tomography/computed tomography (P < 0.001) increased; contrast-enhanced ultrasound (P = 0.028) decreased. The cTNM was significantly different (P < 0.001). The MDTB evaluation increased significantly (P < 0.001). Up-front surgery and exploratory laparotomy decreased (P < 0.001), neoadjuvant treatment increased (P < 0.001). The present study showed the evolving knowledge in surgical oncology of pancreatic cancer at a tertiary referral centre over the time. The different models of care of pancreatic cancer, in particular the introduction of the MDTB and the institution of a pancreas unit to the decision-making process seemed to be influential.
胰腺导管腺癌 (PDAC) 是一种发病率不断增加的疾病,预后较差。本研究旨在评估 2006-2020 年期间在一家三级转诊中心对胰腺癌采用不同治疗模式的效果。对 2006 年 1 月至 2020 年 12 月期间观察到的 PDAC 患者进行回顾性研究。收集并比较了不同时期的人口统计学和临床数据,以及用于影像学技术、术前分期、管理、生存和多学科肿瘤委员会 (MDTB) 评估的数据,这些时期的特点是胰腺癌服务的组织方式不同:时期 A(2006-2010 年);时期 B(2011-2015 年)和时期 C(2016-2020 年)。共分析了 1407 例患者:时期 A 中 441 例(31.3%);B 中 413 例(29.4%);C 中 553 例(39.3%)。患者比例从 31.3%显著增加到 39.3%(P=0.032)。体重指数(P=0.033)、合并症发生率(P=0.002)和卡诺夫斯基表现状态(P<0.001)差异显著。计算机断层扫描(P<0.001)、内镜超声(P<0.001)、细针抽吸、细针活检(P<0.001)和氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(P<0.001)增加;增强超声(P=0.028)减少。cTNM 显著不同(P<0.001)。MDTB 评估显著增加(P<0.001)。直接手术和剖腹探查术减少(P<0.001),新辅助治疗增加(P<0.001)。本研究显示了三级转诊中心随时间推移在胰腺肿瘤外科治疗方面不断发展的知识。胰腺癌的不同治疗模式,特别是 MDTB 的引入和胰腺科室的建立对决策过程的影响。